URGN - UROGEN PHARMA LTD
This page shows which of the focused investors we track hold URGN and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2026 it was held by 1 manager with an aggregate reported value of $1.09M, which is 0.00% of the combined portfolio.
As of Q2 2026, 1 tracked institutional manager held URGN (UROGEN PHARMA LTD) with an aggregate reported value of $1.09M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades URGN — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2026
- Ticker
- URGN
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Polen Capital Management - Polen Capital Management | 0.01% | New | 29,615 | $1.09M |
Loading holder history for URGN…